Literature DB >> 23579092

Risk of multiple sclerosis after a first demyelinating syndrome in an Australian Paediatric cohort: clinical, radiological features and application of the McDonald 2010 MRI criteria.

Esther M Tantsis1, Kristina Prelog, Fabienne Brilot, Russell C Dale.   

Abstract

BACKGROUND: The risk of multiple sclerosis (MS) is dependent on multiple variables, including geographical location. There is increasing interest in the early recognition and treatment of MS in children.
METHOD: Using univariate and multivariate analysis, we determined the clinical and radiological features that were predictive of MS in 88 children from New South Wales, Australia, with a first acute demyelinating syndrome (ADS) who were followed for a minimum of one year. We tested the McDonald, KIDMUS, Callen and Verhey MRI criteria for paediatric MS.
RESULTS: After a mean follow-up of 5.2 years, 13/88 (15%) of children had MS. Using multivariate analysis, preceding infection was protective of MS, and corpus callosal lesions, the combined presence of both well and poorly demarcated lesions, and contrast-enhancing lesions on MRI were predictive of MS. The sensitivity and specificity of the respective radiological criteria were McDonald 2005 (69%, 68%), McDonald 2010 (58%, 95%), KIDMUS (8%, 100%), Callen (69%, 85%) and Verhey (62%, 84%). When McDonald 2010 criteria were applied to baseline and serial scans, the sensitivity and specificity was 91% and 93%.
CONCLUSION: Despite the long follow-up, the risk of MS appears lower in New South Wales children compared to previously reported cohorts. Radiological features are more predictive than clinical features in predicting MS. The McDonald 2010 criteria performed well although the dissemination in time criteria on baseline scans is difficult to apply to children with encephalopathy.

Entities:  

Keywords:  MRI; McDonald 2010 criteria; Multiple sclerosis; acute disseminated encephalomyelitis; clinically isolated syndrome

Mesh:

Year:  2013        PMID: 23579092     DOI: 10.1177/1352458513484377

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  10 in total

Review 1.  Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.

Authors:  Amy Waldman; Angelo Ghezzi; Amit Bar-Or; Yann Mikaeloff; Marc Tardieu; Brenda Banwell
Journal:  Lancet Neurol       Date:  2014-09       Impact factor: 44.182

Review 2.  Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.

Authors:  J Nicholas Brenton; Brenda L Banwell
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

3.  Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton.

Authors:  Russell C Dale; Esther M Tantsis; Vera Merheb; Raani-Yogeeta A Kumaran; Nese Sinmaz; Karrnan Pathmanandavel; Sudarshini Ramanathan; David R Booth; Louise A Wienholt; Kristina Prelog; Damien R Clark; Gilles J Guillemin; Chai K Lim; Emily K Mathey; Fabienne Brilot
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-05-22

Review 4.  MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.

Authors:  Massimo Filippi; Maria A Rocca; Olga Ciccarelli; Nicola De Stefano; Nikos Evangelou; Ludwig Kappos; Alex Rovira; Jaume Sastre-Garriga; Mar Tintorè; Jette L Frederiksen; Claudio Gasperini; Jacqueline Palace; Daniel S Reich; Brenda Banwell; Xavier Montalban; Frederik Barkhof
Journal:  Lancet Neurol       Date:  2016-01-26       Impact factor: 44.182

5.  Landscape of MS patient cohorts and registries: Recommendations for maximizing impact.

Authors:  Bruce F Bebo; Robert J Fox; Karen Lee; Ursula Utz; Alan J Thompson
Journal:  Mult Scler       Date:  2017-03-01       Impact factor: 6.312

6.  Incidence and outcome of acquired demyelinating syndromes in Dutch children: update of a nationwide and prospective study.

Authors:  C L de Mol; Y Y M Wong; E D van Pelt; I A Ketelslegers; D P Bakker; M Boon; K P J Braun; K G J van Dijk; M J Eikelenboom; M Engelen; K Geleijns; C A Haaxma; J M F Niermeijer; E H Niks; E A J Peeters; C M P C D Peeters-Scholte; B T Poll-The; R P Portier; J F de Rijk-van Andel; J P A Samijn; H M Schippers; I N Snoeck; H Stroink; R J Vermeulen; A Verrips; F Visscher; J S H Vles; M A A P Willemsen; C E Catsman-Berrevoets; R Q Hintzen; R F Neuteboom
Journal:  J Neurol       Date:  2018-03-22       Impact factor: 4.849

7.  Real-world validation of the 2017 McDonald criteria for pediatric MS.

Authors:  Yu Yi M Wong; C Louk de Mol; Roos M van der Vuurst de Vries; E Daniëlle van Pelt; Immy A Ketelslegers; Coriene E Catsman-Berrevoets; Rinze F Neuteboom; Rogier Q Hintzen
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-12-14

8.  Predictors of Evolution Into Multiple Sclerosis After a First Acute Demyelinating Syndrome in Children and Adolescents.

Authors:  Laura Papetti; Lorenzo Figà Talamanca; Alberto Spalice; Federico Vigevano; Diego Centonze; Massimiliano Valeriani
Journal:  Front Neurol       Date:  2019-01-15       Impact factor: 4.003

Review 9.  Understanding Childhood Neuroimmune Diseases of the Central Nervous System.

Authors:  Sara Matricardi; Giovanni Farello; Salvatore Savasta; Alberto Verrotti
Journal:  Front Pediatr       Date:  2019-12-19       Impact factor: 3.418

10.  T-cell activation marker sCD27 is associated with clinically definite multiple sclerosis in childhood-acquired demyelinating syndromes.

Authors:  Yu Yi M Wong; Roos M van der Vuurst de Vries; E Daniëlle van Pelt; Immy A Ketelslegers; Marie-José Melief; Annet F Wierenga; Coriene E Catsman-Berrevoets; Rinze F Neuteboom; Rogier Q Hintzen
Journal:  Mult Scler       Date:  2018-07-18       Impact factor: 6.312

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.